How JustAnswer Works:
  • Ask an Expert
    Experts are full of valuable knowledge and are ready to help with any question. Credentials confirmed by a Fortune 500 verification firm.
  • Get a Professional Answer
    Via email, text message, or notification as you wait on our site. Ask follow up questions if you need to.
  • 100% Satisfaction Guarantee
    Rate the answer you receive.
Ask Dr. Michael Salkin Your Own Question
Dr. Michael Salkin
Dr. Michael Salkin, Veterinarian
Category: Veterinary
Satisfied Customers: 29804
Experience:  University of California at Davis graduate veterinarian with 45 years of experience
Type Your Veterinary Question Here...
Dr. Michael Salkin is online now
A new question is answered every 9 seconds

Type your Veterinary dog has reoccurring imt what's the

Customer Question

Type your Veterinary dog has reoccurring imt what's the general prognosis nto question here
Submitted: 11 months ago via Dog-Health-Guide.
Category: Veterinary
Expert:  Dr. Michael Salkin replied 11 months ago.

You're speaking with Dr. Michael Salkin. Welcome to JustAnswer. I'm currently typing up my reply. Please be patient. This may take a few minutes.

Expert:  Dr. Michael Salkin replied 11 months ago.

The prognosis for dogs who recrudesce (relapse without cure in between events) is guarded. When attempts to taper a patient off prednisone fail, treatment with another immunosuppressive drug - mycophenolate (alone) - is used for the long-term.

Melena (bleeding originating in the small intestine) and/or high blood urea nitrogen (BUN) concentration on the serum biochemistry profile have been associated with a worse prognosis in some reports.

To answer you directly, many pets can be completely tapered from immunosuppressive medications although recrudescence remains possible; there's a 9% documented recurrence rate in dogs. Many animals are euthanized due to adverse effects of glucocorticosteroids. Strategies to decreased steroid adverse effects include avoidance of obesity, use of an additional immunosuppressive agent (vincristine, mycophenolate, e.g.) to lower steroid dosage, and routine monitoring for infections of the skin and urinary tract. Stressful circumstances should be avoided if possible to avoid triggering relapse during remission and to reduce the risk of minimal but catastrophic self-trauma during severe thrombocytopenia. Routine monitoring should be scheduled to detect recrudescence of disease and side effects of immunosuppressive medications. Weight must be carefully monitored and obesity avoided.

Please respond with further questions or concerns if you wish.